Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact

por de Vrueh, Remco L. A., Crommelin, Daan J. A.
Publicado 2017

Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?

por Brabers, Anne EM, Moors, Ellen HM, van Weely, Sonja, de Vrueh, Remco LA
Publicado 2011

Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare

por de Vrueh, Remco L. A., de Vlieger, Jon S. B., Crommelin, Daan J. A.
Publicado 2019

Predictors of orphan drug approval in the European Union

por Heemstra, Harald E., de Vrueh, Remco L., van Weely, Sonja, Büller, Hans A., Leufkens, Hubert G. M.
Publicado 2008

Product development programs for neglected tropical diseases: A crucial role for expert meetings

por Hussaarts, Leonie, van der Weijde, Kim, Dome, Pierre, Kourany-Lefoll, Elly, Reinhard-Rupp, Jutta, de Vrueh, Remco
Publicado 2017

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

por Putzeist, Michelle, Mantel-Teeuwisse, Aukje K, Wied, Christine C Gispen-de, Hoes, Arno W, Leufkens, Hubert GM, de Vrueh, Remco LA
Publicado 2013